Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search

The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia

https://doi.org/10.17749/2070-4909.2018.11.3-003-007

Full Text:

Abstract

In the article, we analyze the current version of Government Regulation No. 871 where the principles of health technologies assessment (HTA) and the reimbursement strategies in Russia have been put forward. We conclude that the HTA methodology in Russia is consistent with the multi-criteria decision analysis. Recommendations on the improvement of the assessment methodology in Regulation No. 871 are provided.

About the Authors

V. V. Omelyanovsky
Research Financial Institution of the Ministry of Finance of the Russian Federation, Federal State Budget Institution; Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation.
Russian Federation
Omelyanovsky Vitaliy Vladimirovich – MD, PhD, Professor, Director of the Center for Technology Assessment in Healthcare, Institute of Applied economic Research of RANePA, Head of the Healthcare Finance Center, Research Financial Institute of the Ministry of Finance of the Russian Federation. 3-2 Nastasyinsky pereulok, Moscow 127006; 10-5 Khokhlovskii pereulok, Moscow 109028.


V. K. Fedyaeva
Research Financial Institution of the Ministry of Finance of the Russian Federation, Federal State Budget Institution; Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation.
Russian Federation

Fedyaeva Vlada Konstantinovna – Chief Specialist, Department of Methodology and Support of Comprehensive HTA, Center for Healthcare Quality Assessment and Control, Ministry of Health of the Russian Federation; Laboratory Assistant at the Healthcare Finance Center, Research Financial Institute of the Ministry of Finance of the Russian Federation.

10-5 Khokhlovskii pereulok, Moscow 109028.



N. Z. Musina
Research Financial Institution of the Ministry of Finance of the Russian Federation, Federal State Budget Institution; Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia/
Russian Federation

Musina Nuriya Zagitovna – PhD, Head of the Department of Development and external Communications, Center for Healthcare Quality Assessment and Control, Ministry of Healthcare of the Russian Federation; Lecturer, Department of Pharmacology, Faculty of Pharmacy, I. M. Sechenov First Moscow State Medical University; Senior Researcher, Center for Healthcare Finance, Research Financial Institute, Ministry of Finance of the Russian Federation. 

3-2 Nastasyinsky pereulok, Moscow 127006; 10-5 Khokhlovskii pereulok, Moscow 109028; 8-2 Trubetskaya, Str., Moscow 119048.



References

1. Musina N. Z., Fedyaeva V. K. Metody rascheta QALY kak integral’nogo pokazatelya effektivnosti v protsesse kompleksnoy otsenki lekarstvennyh preparatov. FARMAkoekoNoMIkA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAkoekoNoMIkA. Modern pharmacoeconomics and pharmacoepidemiology (in Russian). 2017; (10) 1: 66-71. DOI: 10.17749/2070-4909.2017.10.1.066-071.

2. Dombrovskiy V. S., Omelyanovskiy V. V. Review of Multicriteria Decision Analysis Application for DecisionMaking in Oncology. Value in health. November 2016; 19 (7): A751.

3. Fedyaeva V. K., Omel’yanovskiy V. V., Rebrova O. Yu. Meditsinskie tekhnologii. otsenka i vybor (in Russian). 2014; 2: 30-35.

4. Federal Law of the Russian Federation No. 323-ФЗ “On the Principles of the Protection of the Health of Citizens in the Russian Federation” of November 21, 2011 [Federal’nyy zakon RF № 323-FZ «ob osnovah ohrany zdorov’ya grazhdan v Rossiyskoy Federatsii» ot 21 noyabrya 2011 g. (in Russian)]/

5. Decree of the Government of the Russian Federation of 28.08.2014 N 871 (ed. Of 12.06.2017) “On approval of the Rules for the formation of the lists of drugs for medical use and the minimum range of drugs needed to provide medical care” [Postanovlenie Pravitel’stva RF ot 28.08.2014 N 871 (red. ot 12.06.2017) “ob utverzhdenii Pravil formirovaniya perechney lekarstvennyh preparatov dlya meditsinskogo primeneniya i minimal’nogo assortimenta lekarstvennyh preparatov, neobhodimyh dlya okazaniya meditsinskoy pomoschi” (in Russian)].

6. Methodical recommendations on multi-criteria analysis of decision-making in health care. FSBI “TSeKKMP” Ministry of Health of Russia (in Russian). [electronic resource] URL: https://rosmedex.ru/ wp-content/uploads/2016/12/MR-MCDA-23.12.2016.pdf. Accessed: 31.06.2018.

7. Omel’yanovskiy V. V., Avksent’eva M. V., Zheleznyakova I. A., Suhorukih O. A., Hachatryan G. R., Galeeva Zh. A., Vlasov V. V., Luk’yantseva D. V., Fedyaeva V. K., Rykov M. Yu. onkopediatriya (in Russian). 2017; 4 (4): 246-259.


For citation:


Omelyanovsky V.V., Fedyaeva V.K., Musina N.Z. The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia. FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology. 2018;11(3):3-7. (In Russ.) https://doi.org/10.17749/2070-4909.2018.11.3-003-007

Views: 128


ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)